CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ammelburg against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) PopulationsIONIS PHARMACEUTICALSMay 22, 2024
Products And CompositionsSILENCE THERAPEUTICSJul 31, 2023
Engineered Natural Killer Cells And Uses ThereofONK THERAPEUTICSMar 21, 2023
Biomarkers For Risk Prediction Of MortalityF HOFFMANN LA ROCHESep 12, 2019
Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative DisordersBRUSCHETTINIJun 4, 2019

Top competitors of Ammelburg

Top competitors of Ammelburg based on patent oppositions.